31 – 40 of 65
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
WILMS’ TUMOUR GENE 1 PROTEIN (WT1) – AN EFFECTOR IN LEUKEMOGENESIS?
- Thesis › Doctoral thesis (compilation)
-
Mark
Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion
- Contribution to journal › Article
-
Mark
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA.
- Contribution to journal › Article
-
Mark
Molecular mechanisms underlying deregulation of C/EBP alpha in acute myeloid leukemia
- Contribution to journal › Scientific review
- 2009
-
Mark
Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies
- Contribution to journal › Scientific review
-
Mark
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.
- Contribution to journal › Article
- 2008
-
Mark
The human SIN3B corepressor forms a nucleolar complex with leukemia-associated ETO homologues
- Contribution to journal › Article
-
Mark
U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner.
- Contribution to journal › Article
- 2007
-
Mark
Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring
- Contribution to journal › Article
-
Mark
Hematopoietic stem cell aging: Mechanism and consequence
- Contribution to journal › Article
